Targeting epigenetics in sarcomas through EZH2 inhibition

Overview of attention for article published in Journal of Hematology & Oncology, April 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 34 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 854 followers.

Targeting epigenetics in sarcomas through EZH2 inhibition. https://t.co/2NuDeV33ik https://t.co/5Qzap6JCg7

26 Jan 2021

Reply Repost Favourite

Super excited, epigenetic targeting(EZH2), driver mutation(loss of INI1) , rare cancer(epitheloid sarc), accelerated approval, and a phase 3 planned.!!! https://t.co/BbBgmxBHIZ

11 Apr 2020

Reply Repost Favourite

Targeting epigenetics in sarcomas through EZH2 inhibition. https://t.co/zjhQCvX6Mt

09 Apr 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.